Campylobacter bacteremia: Clinical features and factors associated with fatal outcome

Clinical Infectious Diseases

Volumn 47, Issue 6, 2008, Pages 790-796

  Pacanowski, Jérôme ^a   Lalande, Valérie ^a   Lacombe, Karine ^a,e,g   Boudraa, Cherif ^a   Lesprit, Philippe ⁱ   Legrand, Patrick ⁱ   Trystram, David ^b   Kassis, Najiby ^j   Arlet, Guillaume ^c,e   Mainardi, Jean Luc ^d,f   Doucet Populaire, Florence ^f,h,k   Girard, Pierre Marie ^a,e,g   Meynard, Jean Luc ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL TENON   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g INSERM   (France)

^h Unité EA 4065   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j HÔPITAL PAUL BROUSSE   (France)

^k CENTRE HOSPITALIER DE VERSAILLES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MACROLIDE; NALIDIXIC ACID; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CAMPYLOBACTER; CAMPYLOBACTER FETUS; CELLULITIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DEATH; DEVICE INFECTION; DIARRHEA; FATALITY; FEMALE; FRANCE; GERIATRIC PATIENT; HOSPITAL; HUMAN; IMMUNOCOMPROMISED PATIENT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NEOPLASM; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION; SPECIES IDENTIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CAMPYLOBACTER; CAMPYLOBACTER FETUS; CAMPYLOBACTER INFECTIONS; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PARIS; YOUNG ADULT;

EID: 51549090963     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/591530     Document Type: Article

References (33)

1. Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607-25.
2. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001; 32:1201-6.
3. Streit JM, Jones RN, Toleman MA, Stratchounski LS, Fritsche TR. Prevalence and antimicrobial susceptibility patterns among gastroenteritis- causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents 2006; 27:367-75.
4. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 sites, United States, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:352-6.
5. Blaser MJ. Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone, 2006:2548-57.
6. Blaser MJ. Editorial response: Campylobacter fetus - emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis 1998; 27:256-8.
7. Schonheyder HC, Sogaard P, Frederiksen W. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis 1995; 27:145-8.
8. Reed RP, Friedland IR, Wegerhoff FO, Khoosal M. Campylobacter bacteremia in children. Pediatr Infect Dis J 1996; 15:345-8.
9. Pigrau C, Bartolome R, Almirante B et al. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 1997; 25:1414-20.
10. Tee W, Mijch A. Campylobacter jejuni bacteremia in HIV-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 1998; 26:91-6.
11. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect 1993; 110: 567-73.
12. Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J Clin Microbiol 2003; 41: 463-6.
13. Tajada P, Gomez-Garces JL, Alos JI, Balas D, Cogollos R. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 β-lactam agents and combination with b-lactamase inhibitors. Antimicrob Agents Chemother 1996; 40:1924-5.
14. Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother 1998; 42:1847-9.
15. Gaudreau CL, Lariviere LA, Lauzer JC, Turgeon FF. Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight b-lactam antibiotics. Antimicrob Agents Chemother 1987; 31: 940-2.
16. Lachance N, Gaudreau C, Lamothe F, Lariviere L. Role of the b-lactamase of Campylobacter jejuni in resistance to β-lactam agents. Antimicrob Agents Chemother 1991; 35:813-8.
17. Schmidt U, Chmel H, Kaminski Z, Sen P. The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med 1980; 49:431-42.
18. Guerrant RL, Lahita RG, Winn WC, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med 1978; 65:584-92.
19. Francioli P, Herzstein J, Grop JP, Valloton JJ, Glauser MP. Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med 1985; 145: 289-92.
20. Morrison VA, Lloyd BK, Chia JKS, Tuazon CU. Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 1990; 12:387-92.
21. Wang WLL, Blaser MJ. Detection of pathogenic Campylobacter species in blood culture systems. J Clin Microbiol 1986; 23:709-14.
22. Ichiyama S, Hirai S, Minami T, et al. Campylobacter fetus supspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 1998; 27:252-5.
23. Monselise A, Blickstein D, Ostfeld I, Segal R, Weinberger M. A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis 2004; 23:718-21.
24. Chambers ST, Morpeth SC, Laird HM. Campylobacter fetus prosthetic hip joint infection: successful management with device retention and review. J Infect 2005; 50:258-61.
25. Peetermans WE, de Man F, Moerman P, van de Werf F. Fatal prosthetic valve endocarditis due to Campylobacter fetus. J Infect 2000; 41:180-2.
26. Gaudreau C, Gilbert H. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, Canada. Antimicrob Agents Chemother 2003; 47:2027-9.
27. Karmali MA, de Grandis S, Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother 1980; 18:948-51.
28. Karmali MA, de Grandis S, Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother 1981; 19:593-7.
29. Kwon SY, Cho DH, Lee SY, Lee K, Chong Y. Antimicrobial susceptibility of Campylobacter fetus subsp. fetus isolated from blood and synovial fluid. Yonsei Med J 1994; 35:314-9.
30. Morroka T, Oda T. In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subsp. fetus. Pediatr Infect Dis J 1989; 8:653-4.
31. Spelhaug DR, Gilchrist MJR, Washington JA. Bactericidal activity of antibiotics against Campylobacter fetus subsp. intestinalis. J Infect Dis 1981; 143:500.
32. Engberg J, Neimann J, Nielsen EM, Aerestrup FM, Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 2004; 10:1056-63.
33. Engberg J, Aarestrup FM, Taylor DE, et al. Quinolone and macrolide resistance in Campylobacter jejuni and Campylobacter coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001; 7: 24-34.